US 11702417
Compounds for improving mRNA splicing
granted A61PA61P25/28
Quick answer
US patent 11702417 (Compounds for improving mRNA splicing) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P25/28